Access Bio, Inc. (KOSDAQ:950130)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Manufacturing and Selling in Vitro Diagnostic Kits	112.46B	348.64B	1.03T	505.11B	121.80B
Manufacturing and Selling in Vitro Diagnostic Kits Growth	-67.74%	-66.28%	104.68%	314.71%	182.86%
Total	112.46B	348.64B	1.03T	505.11B	121.80B
Total Growth	-67.74%	-66.28%	104.68%	314.71%	182.86%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Africa	1.70B	1.22B	758.78M	6.70B	12.45B
Africa Growth	38.85%	61.13%	-88.68%	-46.18%	-55.42%
Oceania	-	4.93M	162.12B	40.57B	826.38M
Oceania Growth	-	-100.00%	299.59%	4809.64%	-25.01%
America	85.78B	331.35B	813.03B	446.54B	79.37B
America Growth	-74.11%	-59.24%	82.07%	462.64%	10492.76%
Europe	126.69M	37.25M	107.31M	1.51B	1.40B
Europe Growth	240.09%	-65.28%	-92.89%	7.56%	-61.04%
Asia	34.20B	13.72B	30.37B	30.41B	18.28B
Asia Growth	149.35%	-54.83%	-0.16%	66.40%	97.24%
Total	121.80B	346.33B	1.01T	525.74B	112.32B
Total Growth	-64.83%	-65.59%	91.42%	368.06%	163.39%

Source: S&P Global Market Intelligence.